Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine vs Opioids for Perioperative Cardiovascular Protection
NCT04553536Recruiting
- Sponsor
- The Second Hospital of Shanxi Medical University
- Start
- Nov 2020
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of esketamine in postoperative pain (2 arms), sponsored by The Second Hospital of Shanxi Medical University. Primary endpoints: Perioperative adverse cardiac events at 72 hours, Transient Receptor Potential Vanilloid 1 at 24 hours and 2 more. Started Nov 2020; status: recruiting.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04553536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04553536.